MASTERINVEST Kapitalanlage GmbH Acquires New Position in Cigna Group $CI

MASTERINVEST Kapitalanlage GmbH bought a new position in shares of Cigna Group (NYSE:CI) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 8,109 shares of the health services provider’s stock, valued at approximately $2,235,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Wilkerson Advisory Group LLC acquired a new position in Cigna Group in the fourth quarter valued at $25,000. Osbon Capital Management LLC acquired a new stake in Cigna Group in the 2nd quarter worth about $26,000. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group in the 4th quarter worth about $29,000. Prosperity Bancshares Inc purchased a new stake in Cigna Group in the 4th quarter valued at about $29,000. Finally, Cedar Mountain Advisors LLC increased its stake in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total transaction of $5,369,583.72. Following the completion of the sale, the insider directly owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This trade represents a 41.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 23,012 shares of company stock worth $6,386,550 over the last three months. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Stock Down 1.3%

Shares of NYSE CI opened at $277.21 on Friday. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The company has a market cap of $73.25 billion, a P/E ratio of 11.47, a P/E/G ratio of 0.97 and a beta of 0.29. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68. The stock has a fifty day moving average price of $283.53 and a 200 day moving average price of $281.41.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, topping analysts’ consensus estimates of $7.60 by $0.18. The company had revenue of $70.04 billion for the quarter, compared to analysts’ expectations of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The firm’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Research analysts anticipate that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is 25.82%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on CI shares. Wells Fargo & Company increased their price objective on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. UBS Group upped their price target on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. The Goldman Sachs Group increased their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Wolfe Research reiterated an “outperform” rating and issued a $315.00 price target on shares of Cigna Group in a report on Tuesday, June 16th. Fifteen equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.